Catalent
CTLT
#1756
Rank
โ‚ฌ10.50 B
Marketcap
57,87ย โ‚ฌ
Share price
0.00%
Change (1 day)
19.64%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -5,89ย โ‚ฌ

According to Catalent's latest financial reports the company's current EPS (TTM) is -5,77ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,20ย โ‚ฌ a decrease over its 2022 EPS that were of 2,07ย โ‚ฌ.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-5,89ย โ‚ฌ-4.96%
2023-6,20ย โ‚ฌ-399.56%
20222,07ย โ‚ฌ-30.58%
20212,98ย โ‚ฌ79.67%
20201,66ย โ‚ฌ114.12%
20190,77ย โ‚ฌ-15%
20180,91ย โ‚ฌ75.44%
20170,52ย โ‚ฌ-22.97%
20160,67ย โ‚ฌ-59.56%
20151,67ย โ‚ฌ282.05%
20140,44ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-0,69ย โ‚ฌ-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
3,31ย โ‚ฌ-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-0,68ย โ‚ฌ-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-1,35ย โ‚ฌ-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA